Sydney P. Wendt, A. Gordon, Anshul Bhatnagar, S. Orengo‐Nania, K. Biggerstaff, Sumitra S. Khandelwal
{"title":"Comparison of Five-Year Graft Survival After Keratoplasty in the Veteran Population","authors":"Sydney P. Wendt, A. Gordon, Anshul Bhatnagar, S. Orengo‐Nania, K. Biggerstaff, Sumitra S. Khandelwal","doi":"10.1097/ebct.0000000000000010","DOIUrl":null,"url":null,"abstract":"\n \n We investigated the corneal graft survival rate after penetrating keratoplasty (PK) and Descemet stripping endothelial keratoplasty (DSEK) in a veteran population.\n \n \n \n A retrospective review was conducted on patients undergoing a primary PK or DSEK at a large Veterans Affairs Medical Center between January 2005 and August 2019. Exclusion criteria included patients with a postoperative follow-up less than 5 years and patients undergoing additional ocular procedures during surgery. Patients were classified into 3 groups depending on their glaucoma status before corneal transplant: no pre-existing glaucoma, medically managed glaucoma, or surgically managed glaucoma. Graft survival was calculated using the Kaplan–Meier survival analysis.\n \n \n \n A total of 30 eyes underwent PK, and 28 eyes underwent DSEK. There was no significant difference in graft survival rates between PK and DSEK at 1 year (83% vs. 79%, P = 0.555), 3 years (53% vs. 64%, P = 0.536), and 5 years (40% vs. 54%, P = 0.399). When combining PK and DSEK groups, Kaplan–Meier analysis showed a highly significant difference in 5-year graft survival between patients without pre-existing glaucoma (58%) and patients with either medically (50%) or surgically managed glaucoma (0%).\n \n \n \n We find approximate parity in 1-year, 3-year, and 5-year survival rates after PK and DSEK within the veteran population. However, survival rates for both procedures are lower than those previously reported within other populations. Additional studies to understand these differences in larger cohorts are warranted. Ophthalmologists must understand the increased risk of graft failure in the veteran population to provide appropriate counseling.\n","PeriodicalId":225499,"journal":{"name":"Eye Banking and Corneal Transplantation","volume":"53 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eye Banking and Corneal Transplantation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ebct.0000000000000010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
We investigated the corneal graft survival rate after penetrating keratoplasty (PK) and Descemet stripping endothelial keratoplasty (DSEK) in a veteran population.
A retrospective review was conducted on patients undergoing a primary PK or DSEK at a large Veterans Affairs Medical Center between January 2005 and August 2019. Exclusion criteria included patients with a postoperative follow-up less than 5 years and patients undergoing additional ocular procedures during surgery. Patients were classified into 3 groups depending on their glaucoma status before corneal transplant: no pre-existing glaucoma, medically managed glaucoma, or surgically managed glaucoma. Graft survival was calculated using the Kaplan–Meier survival analysis.
A total of 30 eyes underwent PK, and 28 eyes underwent DSEK. There was no significant difference in graft survival rates between PK and DSEK at 1 year (83% vs. 79%, P = 0.555), 3 years (53% vs. 64%, P = 0.536), and 5 years (40% vs. 54%, P = 0.399). When combining PK and DSEK groups, Kaplan–Meier analysis showed a highly significant difference in 5-year graft survival between patients without pre-existing glaucoma (58%) and patients with either medically (50%) or surgically managed glaucoma (0%).
We find approximate parity in 1-year, 3-year, and 5-year survival rates after PK and DSEK within the veteran population. However, survival rates for both procedures are lower than those previously reported within other populations. Additional studies to understand these differences in larger cohorts are warranted. Ophthalmologists must understand the increased risk of graft failure in the veteran population to provide appropriate counseling.
我们调查了一名退伍军人在穿透性角膜移植术(PK)和Descemet剥离内皮角膜移植术(DSEK)后角膜移植的存活率。对2005年1月至2019年8月在一家大型退伍军人事务医疗中心接受原发性PK或DSEK的患者进行了回顾性研究。排除标准包括术后随访少于5年的患者和手术期间接受额外眼科手术的患者。根据患者在角膜移植前的青光眼状况,将患者分为3组:无青光眼、药物治疗青光眼和手术治疗青光眼。采用Kaplan-Meier生存分析计算移植物存活。共30只眼行PK, 28只眼行DSEK。PK和DSEK在1年(83% vs. 79%, P = 0.555)、3年(53% vs. 64%, P = 0.536)和5年(40% vs. 54%, P = 0.399)时移植物存活率无显著差异。当PK组和DSEK组联合使用时,Kaplan-Meier分析显示,无既往青光眼患者(58%)与药物治疗(50%)或手术治疗青光眼患者(0%)的5年移植物生存率有显著差异。我们发现,在退伍军人人群中,PK和DSEK后的1年、3年和5年生存率大致相同。然而,这两种手术的存活率都低于先前在其他人群中报道的存活率。有必要在更大的队列中进行进一步的研究,以了解这些差异。眼科医生必须了解退伍军人移植失败的风险增加,以便提供适当的咨询。